Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria

Chin-Chung Wu1, Mei-Ling Chan, Wen-Ying Chen

  • 1Graduate Institute of Natural Products, Kaohsiung Medical University, 100 Shin-Chuan 1st Road, Kaohsiung, Taiwan. ccwu@kmu.edu.tw

Insights

Pristimerin induces apoptosis in human breast cancer cells by directly targeting mitochondria, leading to cytochrome c release. This natural compound shows potential as a novel chemotherapeutic agent for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Pristimerin, a natural triterpenoid, exhibits cytotoxicity against various cancer cell lines.
  • The precise mechanism underlying pristimerin's cytotoxic effects remains largely unexplored.

Purpose of the Study:

  • To elucidate the mechanism of pristimerin-induced cytotoxicity in human breast cancer cells.
  • To investigate pristimerin's effects on apoptosis and mitochondrial function.

Main Methods:

  • Human breast cancer MDA-MB-231 cells were treated with pristimerin.
  • Assays included caspase activation, DNA fragmentation, mitochondrial membrane potential, and cytochrome c release.
  • Involvement of Bcl-2 family proteins and reactive oxygen species was assessed.
  • Cell-free experiments with isolated mitochondria were performed.

Main Results:

  • Pristimerin rapidly induced apoptosis, evidenced by caspase activation and DNA fragmentation.
  • Mitochondrial cytochrome c release preceded caspase activation and was independent of Bcl-2 family proteins or reactive oxygen species.
  • Pristimerin directly induced cytochrome c release from isolated mitochondria.
  • Benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (a pan-caspase inhibitor) blocked apoptosis, but not cytochrome c release.

Conclusions:

  • Pristimerin is a novel mitochondria-targeted compound.
  • Its mechanism involves direct induction of mitochondrial cytochrome c release, triggering apoptosis.
  • Pristimerin warrants further investigation as a potential chemotherapeutic agent for human cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...